Standalone Audited Financial Results for the quarter and year ended March 31, 2025, together with Audit Report thereon;<BR> <BR> Recommended a Dividend of Rs. 9 per equity share of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.9 pts less than Nifty Microcap 250 and 8.5 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TANFAC Industries posted strong FY25 results with revenue from operations rising about 47% year-on-year to Rs. 556.98 crore, up from Rs. 378.15 crore in FY24. Profit after tax for the year grew roughly 68% to Rs. 88.15 crore versus Rs. 52.48 crore in the previous year, with EPS rising to Rs. 88.37 from Rs. 52.61. The Q4 performance was even sharper, with revenue up around 67% and PAT up about 80% year-on-year, helped by commercial production starting from the Hydrofluoric Acid expansion project at Cuddalore on October 7, 2024. The Board has recommended a 90% dividend of Rs. 9 per share on the face value of Rs. 10, subject to shareholder approval. Statutory auditor Singhi & Co. issued an unmodified (clean) opinion on the results.
Shareholders stand to benefit from a healthy 90% dividend on top of strong profit growth, while the stock may get a positive read from the clean audit, robust top-line expansion, and ramp-up of the new HF acid capacity. Investors should note fresh borrowings of about Rs. 41.4 crore have appeared on the balance sheet, likely tied to the expansion project.